Gene · 406919
MIR130A: microRNA 130a
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. MIR130A: microRNA 130a. Genes, record 406919. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/406919
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,202
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MIR130A papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 9 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 7 | 2025 |
| R01HL124021 | An endothelial-fibroblast axis connecting senescence to amino acid metabolism for control of vascular stiffness in PAH | 6 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 5 | 2025 |
| P30CA076292 | Moffitt Cancer Center Support Grant | 5 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 4 | 2025 |
| P30CA023074 | University of Arizona Cancer Center - Cancer Center Support Grant | 4 | 2025 |
| P30ES009089 | Center for Environmental Health in Northern Manhattan | 4 | 2025 |
| R01HL076485 | Engineering Vascularized Cardiac Muscle | 3 | 2025 |
| T32HL007381 | Cardiovascular Sciences Training Grant | 3 | 2025 |
1 to 10 of 1,202Source NIH's project files
See all 1,202 nih grantsPapers3,220
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Compensated iron depletion in repeated blood donations: Stability of circulating microRNAs despite reduced ferritin stores. | Vox Sang | 2026 | 42574134 | PubTator, text mining | PubMed |
| Tissue MicroRNAs in Arrhythmogenic Cardiomyopathy: A Systematic Review of Studies in Human Myocardium and Animal Models with Implications for Post-Mortem Molecular Diagnostics. | Genes (Basel) | 2026 | 42353884 | PubTator, text mining | PubMed |
| MicroRNA, MicroRNA-lncRNA and MicroRNA-Circular RNA axes, and exosomal MicroRNAs: driving exercise-induced cardioprotection in heart failure. | Front Cell Dev Biol | 2026 | 41960190 | PubTator, text mining | PubMed |
| HIF-1α suppresses SNPH expression to facilitate liver metastasis of colorectal cancer through regulating mitochondrial dynamics and filopodia formation. | Cell Death Dis | 2026 | 41888092 | PubTator, text mining | PubMed |
| Mechanistic insights and therapeutic potential of sphingosine‑1‑phosphate in the development of pulmonary fibrosis (Review). | Mol Med Rep | 2026 | 41860030 | PubTator, text mining | PubMed |
| Pilot study of dual-arm absolute quantification of miR-130a and miR-365a in plasma and urine reveals 3p/5p strand-ratio shifts in prostate cancer. | Sci Rep | 2026 | 41813789 | PubTator, text mining | PubMed |
| Strategies to target PD-1/PD-L1 in the tumor microenvironment. | Cell Oncol (Dordr) | 2026 | 41784760 | PubTator, text mining | PubMed |
| The Role and Mechanisms of miRNAs on Ovarian Granulosa Cells: A Literature Review. | Genes (Basel) | 2026 | 41751505 | PubTator, text mining | PubMed |
| miRNA-Based Breast Cancer Subtyping Using AHALA Multi-Stage Classification Approach. | Cancers (Basel) | 2026 | 41749839 | PubTator, text mining | PubMed |
| Broadband Nanocavity Imaging with Machine Vision for Multiplex miRNA Assays. | Adv Mater | 2026 | 41738572 | PubTator, text mining | PubMed |
1 to 10 of 3,220
See all 3,220 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/406919
GET https://conductscience.org/api/genes/v1/406919/grants?page=2